A composite lymph node-targeting nanoadjuvant NA@DCM integrates TLR9 and mitochondrial metabolic reprogramming for enhanced hepatitis B vaccination

Materials Today Bio · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles